Operator linking

March 11, 2010

Transplantation of organs from animals to humans could soon be a reality

Filed under: Uncategorized — operatorlinking @ 7:08 am

Scientists now believe the transplantation of organs from animals to humans could soon be a reality.

Speaking at the BA Festival of Science in Dublin, Dr Anthony Warrens, discussed how xenotransplantation, the process of transplanting organs from one species into another, could soon be a reality, easing the current shortage of organs for transplantation.


Dr Anthony Warrens, from Imperial College London and Hammersmith Hospital, says: “Although the idea of xenotransplantation is far from new, it is only in recent years that many of the potential immunological problems, such as transplant rejection, have been solved, meaning the process of transplanting organs from one species into another, could soon be a reality.”


“With the increasing shortage of donors for organ transplants, the use of animal organs may be the only hope for many suffering from problems such as kidney, heart or lung failure.”


Despite the progress made in this field there are still a number of problems associated with transplanting animal organs into humans. The dangers of animal viruses crossing over and infecting humans are still a cause for concern, as researchers have been unable to create an animal model to test the likelihood and extent of any cross over.


In addition, unknown animal pathogens could prove a potential problem.


While scientists can create treatment and transplant rejection prevention strategies for known human pathogens, they are unable to do so for animal pathogens, whose effects on humans may not be fully known.


Dr Warrens adds: “Despite the risks, xenotransplantation may be the best hope we have for dealing with the current transplant shortage. Currently there are around 6000 on the kidney transplant waiting list, whose condition will only get worse without a transplant. Although we can’t say there is absolutely no danger of cross infection, I believe that in the future we will be able to deal with many of the problems, reducing any potential risk.”


http://www.imperial.ac.uk

March 9, 2010

New generation drug-eluting stent demonstrates equivalent efficacy to market leader in ‘real world’

Filed under: Uncategorized — operatorlinking @ 10:53 pm

In the chief reading of its kind, a benumb-eluting stent (DES) with a biodegradable polymer applied only to the outer surface has been demonstrated as right and effective as one of the most established and widely used types of DES with a persistent polymer, in equivalent conditions to everyday clinical practice.

The LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Study randomly assigned 1,707 patients with 2,472 lesions to treatment with either a biolimus-eluting stent with a biodegradable polymer or a sirolimus-eluting stent with a durable polymer. The study involved a broad range of patients for whom a stenting procedure was considered suitable, designed to reflect routine clinical practice.


Nine months after the procedure, the numbers of deaths, heart attacks and repeat interventions required because of renewed blood vessel narrowing were equivalent in both treatment groups (9.2% of patients in the biolimus-eluting stent group and 10.5% of patients in the sirolimus-eluting stent group). In the one in four patients given an angiogram, the degree of blood vessel narrowing at the site of stent implantation was also equivalent in both treatment groups.


The DES is designed to treat narrowing of coronary arteries which is one of the principal causes of coronary artery disease. Once implanted, it uses the strength of its cylindrical mesh wall to keep the artery widened and maintain blood flow, and gradually releases its drug into the surrounding tissues. The role of the drug is to inhibit restenosis, a common problem following stent implantation, whereby excessive tissue forms around the stent and may negate the benefit that it provides. First-generation drug-eluting stents released the drug from a durable polymer, which may be associated with the formation of blood clots (thrombosis) more than a year after implantation. A new generation of DES has therefore been developed, using a polymer which is completely degraded into carbon dioxide and water after 6-9 months leaving only the metal mesh behind, more closely resembling a bare metal stent.


“The results from LEADERS are significant, as they demonstrate for the first time that a drug-eluting stent with a biodegradable polymer is just as safe and effective as a conventional drug-eluting stent with a durable polymer, under conditions which resemble those of routine clinical practice�, commented LEADERS Principle Investigator Professor Stephan Windecker, University Hospital, Bern, Switzerland. “The next stage will be to investigate whether a biodegradable polymer leads to a lower risk of stent thrombosis in the longer term�.


http://www.escardio.org

March 7, 2010

Bioject Enters Into A Collaborative Research Agreement With IAVI For The Delivery Of An HIV Vaccine Candidate

Filed under: Uncategorized — operatorlinking @ 1:23 am

Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading developer of needle-manumitted injection therapy systems, today announced that it has entered into an agreement with the Cosmopolitan AIDS Vaccine Initiative (IAVI) to supply its unparalleled Needle-Unconditional Injection Therapy (NFIT) system, the Biojector® 2000, for the delivery of a DNA-based HIV vaccine office-seeker that is currently under development. The new agreement extends during December 2009.

IAVI and the St. Stephen’s AIDS Trust at the Chelsea and Westminster Clinic have initiated a Phase I clinical trial in London, UK to analysis a prime-boost combination of two HIV vaccine candidates. One of the vaccine candidates, a DNA-based vaccine called ADVAX, commitment be administered using the Biojector® 2000.

“We welcome this collaboration with Bioject to assess the value of their needle-free device with a view the delivery of this DNA HIV vaccine candidate,” said Dr. Pat Fast, Chief Medical Officer at IAVI. “It is principal that we enhance immune responses against HIV, which may be achieved by optimizing vaccine design, but also by evaluating alternative vaccine delivery methods.”

The proof in London includes ADVAX to prime the immune system preceding to the administration of an MVA-based HIV vaccine entrant called TBC-M4. In a previous Usher in I trial, TBC-M4 generated modest immune responses in all volunteers who received the highest dose. The explanation for combining TBC-M4 with ADVAX is to improve immune activation. Previous Discontinue I studies with different DNA and MVA-based HIV vaccines in solution have shown that this prime-boost regimen was safe and well tolerated, and also gifted to generate enhanced exempt responses when compared with the responses generated by either vaccine alone. Furthermore, DNA-based vaccine candidates such as ADVAX may offer value economically, since these vaccines are relatively inexpensive and easy to manufacture, two characteristics that make them particularly appealing for use in the developing world.

impotencia masculina

ADVAX will be administered with the Biojector® 2000 needle-detach injection way. “Needle-freely injection of a DNA vaccine can provide enhanced immune responses compared with administration by needle and syringe,” said Dr. Richard Stout, Numero uno Vice President and Chief Medical Officer of Bioject. “We are somewhat pleased that IAVI has definite to utilize Bioject’s B2000 system in order to explore the potential benefits over needle and syringe,” commented Dr. Stout.

The advancement of a safe and effective AIDS vaccine is one of the greatest priorities in global constitution R&D. Today, 33 million people worldwide are living with HIV and 7,500 are newly infected every day. It is vital to contain both midget-term and long-term solutions to this trouble. Treatment must reach those who are infected, and proven prevention tools need to be made close by to those who penury it. At the same time, greater investment is needed to develop new and advantage tools to improve mastery and prevention of HIV infection. An AIDS vaccine offers the maximum effort hope for achieving this and to become conscious a world without AIDS.

About the AIDS vaccine candidates and the trial

TBC-M4 was designed by a biotech cartel in the U.S. in collaboration with Dr. Sekhar Chakrabarty from the Citizen Institute of Cholera and Enteric Diseases (NICED) in Kolkata, India. ADVAX was designed by the Aaron Diamond Research Centre in New York, totally collaboration with Rockefeller University in New York and IAVI. The Phase I trial in London is sponsored by IAVI and conducted in collaboration with the St. Stephen’s AIDS Trust in London, UK.

About Bioject

Bioject Medical Technologies Inc., based in Portland, Oregon, is an innovative developer and manufacturer of needle-free injection therapy systems (NFITS). NFITS accommodate an empowering technology and works by forcing medication at violent scurry through a itty-bitty orifice held against the skin. This creates a fine creek of high-pressure ichor penetrating the skin and depositing medication in the tissue beneath. The Company is focused on developing mutually healthy agreements with matchless pharmaceutical, biotechnology, and veterinary companies.

Bioject Medical Technologies Inc.

March 4, 2010

Princeton Dentist

Filed under: Uncategorized — operatorlinking @ 6:38 pm

Princeton, Revitalized Jersey may be best known as the family to Princeton University but it is also a strong community. The residents of the compass is around 30,000. There are quantity of general dentists in the area with wide people for every 600 residents. There are also a number of specialized dental practices in the Princeton, New Jersey parade including pediatric dentists.

Finding the right general dentist is important for your oral health. You need to find a dentist that you are comfortable working with, one that you can afford to visit on a regular basis and one that has time to devote to your specific needs.

Tips for Finding a Dentist in Princeton

• Check with your insurance. Many plans do not cover dental care but you may be able to purchase an addition to your policy. Insurance policies that do cover dental care may limit that coverage to specific dentists.

• Talk to friends and family. Get opinions about dentists from those that you trust the most.

• Do some research. The internet is a great tool for finding all of the dental practices in the Princeton area.

• Meet with the dentist that you are considering. You are not just looking for competence but also a personal dynamic that makes you feel comfortable and welcomed.

cialis

• Check with the licensing board. New Jersey regulates the dental industry and will have listings of all its licensed practices in Princeton.

• Be flexible. It may be that the dentist that is perfect for you does not work out for your children. Be willing to put the same effort into finding the right dentist for the whole family.

Keep in mind that you can change dentists at any time. It is your oral health that is on the line so feel free to look for a new dentist in Princeton any time that you begin to feel like your current care is lacking.

Ross H is a sponsored writer for Dr. Cortese. For your Princeton dental implants needs in the New Jersey area, contact Dr. Cortese.

March 2, 2010

Research News From The Journal Of The Science Of Food And Agriculture; Honeydew Honeys Are Better Antioxidants Than Nectar Honeys

Filed under: Uncategorized — operatorlinking @ 3:23 am

A inquiry of 36 Spanish honeys from different floral origins revealed that honeys generated by bees feeding on honeydew have greater antioxidant properties than those produced by bees feeding on nectar. The study is published in this month’s copy of the Catalogue of the Skill of Food and Agriculture.

Actually occurring antioxidants are important ingredients of sundry foods, and keenly sought in innumerable ‘health foods’. They are believed to help protect people from diseases same cancer, cardiovascular disorders, neurodegenerative diseases and aging. They operate by mopping up potentially damaging free radicals that are released in the body. Honey is a man source of antioxidants.

The composition of honey depends greatly on where honeybees collect their raw materials. There are two key types of source. First, honeybees can collect nectar from flowers, and this generates nectar honeys. Secondly they can collect fluids that exude from plants, all things considered after the plants cause been visited by a bush-sucking insect and this generates honeydew honeys.

“Honey is a natural source of antioxidants, and among honeys, honeydew honey is the best,” says researcher Rosa Ana Pérez, who works at the Instituto Madrileño de Investigación y Desarrollo Georgic, Agrario y Alimentario, in Madrid, Spain.

Each of the 36 honeys was exposed to a wander of physical and chemical tests. Honeys with high antioxidant properties (measured by the DPPH test) also had high total polyphenol content, grille absorbance (as colour parameter), pH and electrical conductivity.

“These laboratory results show some aspects that people could use to win over get an thought close to which honeys are likely to have the most potent antioxidant properties,” says Pérez.

About JOHN WILEY & SONS

Wiley is a leading publisher for the thorough, technological, and medical (STM) communities worldwide. Our STM programs encompass journals, encyclopedias, and electronic products in subjects such as the life and medical sciences, chemistry, statistics and mathematics, electrical and electronics engineering, and select medical areas with an attention on cancer medicine. Through Wiley InterScience, we provide speculative and corporate customers with online access to a latitudinarian range of STM content through licensing agreements.

Viagra comprar


JOHN WILEY & SONS
The Atrium
Southern Gate
Chichester
PO 19 8SQ
http://www.wiley.com

February 28, 2010

New York Times Examines Japanese Car Makers’ Health Care Plans For U.S. Retirees

Filed under: Uncategorized — operatorlinking @ 10:48 pm

The New York Times on Friday examined how workers at Japanese car companies in the U.S. “will bear much more of the costs and the risks of retirement on their own” compared with retirees from the Big Three U.S. automakers. Retirees of Japanese companies in the U.S. “pay character of their health be responsible for costs,” and the companies’ “pension obligations are a fraction of that of the American carmakers,” according to the Times. The “difference adds up to an well-connected price harm for the Big Three” as they try to regain vend portion and face “enormous” unfunded liabilities for condition care and allotment costs, the Times reports. For example, Extended Motors in 2005 paid $5.4 billion for the health benefits of 141,000 workers, 449,000 retirees and their dependents. Meanwhile, Toyota in its 2005 annual divulge said “its obligations to duvet the health fancy expenses for its retirees ‘are not material,’” the Times reports. Pete Gritton, human resources vice-president respecting Toyota’s U.S. manufacturing operations, said, “We want to avoid commitments when we have no control over their costs. We can’t build in things in such a way that we won’t be able to keep our commitments later.” Although the Japanese retirement packages “carry no uncertainty” for the companies, “they do for workers, whose retreat eggs depend on their contributions and the financial markets,” according to the Times (Porter, New York Times, 5/19).

“Reprinted with leniency from http://www.kaisernetwork.org. You can view the thorough Kaiser Daily Health Policy Description, search the archives, or whistle up because email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Form Policy Announce is published for the purpose kaisernetwork.org, a free service of The Henry J. Kaiser Family Substructure . © 2005 Advisory Live Coterie and Kaiser Family Fundamental principle. All rights withdrawn.

viagra generico en españa

February 26, 2010

How Cow Warts, Clergy Sex Surveys Moved Along Cancer Vaccine

Filed under: Uncategorized — operatorlinking @ 1:28 am

The creation of a successful vaccine against cervical cancer, approved by the U.S. Food and Drug Administration, is the culmination of research that occurred thanks not exclusive to scientists and physicians, but also to generous farmers and veterinarians, priests and nuns agreeable to tell all - and some very patient cows.

At the University of Rochester Medical Center, the initial dig into more than 20 years ago included visits to veterinarians and sustenance-packaging plants in Upstate New York to collect scrapings from “prized” cow warts, and surveys of people inauspicious to be infected with a sexually transmitted disease - priests and nuns who had taken a vow of celibacy.

The work with the cows, the warts, the nuns and the priests illustrates how basic up on can pay off in big and unexpected ways. The examination by a trio of University of Rochester virologists - William Bonnez, M.D., Richard Reichman, M.D., and Robert Rose, Ph.D. - helped bring more the cervical cancer vaccine, poised to prevent cancer in thousands of people. The University is one of several institutions in whose laboratories work on an HPV vaccine blossomed. Rochester’s contribution is recognized with a conspicuous issued by the European Patent Employment and by nobility agreements with the companies commercializing the vaccine.

The scrutiny project in Rochester began with an effort to forth a blood test to find infection by a classify of viruses known as human papillomaviruses or HPV, which cause warts as fit as cervical cancer. To do so, the researchers needed obese amounts of papillomavirus - and while there are tons of warts in this elated, finding people content to compile and analyze them is quite a different story. So as a starting point the crew turned to bovine papillomavirus or BPV in cows, and Bonnez found himself visiting veterinarians and others with access to cows with warts, seeking samples.

In the world of warts, cows offer a particularly profuse lode of papillomavirus, Bonnez said, because they are particularly rich in viral particles. Numberless other warts, such as genital warts in humans, don’t provide adequately viral particles.

The trips to the countryside were successful - Bonnez ultimately collected enough cow warts and still keeps a stash in his laboratory freezer - and the digging moved ahead. The next step involved assessing the evaluation, and doctors needed a monstrous control group of adults who were unlikely to have been infected with genital HPV. So the group turned to area nuns and priests who allowed themselves to be polled about their sexual intercourse lives and who donated blood samples. (Clergy suffer with been crucial to other Rochester research projects as well; several have volunteered to investigation HIV vaccines, for instance.)

A few years into the project, the scientists faced difficulty improving their blood test using BPV, so they scrapped the cow warts and learned to cultivate human HPV in the laboratory. Soon after that they discovered that the three-dimensional outer shell of the virus was crucial to creating an immune feedback that could block infection.

The scientists then turned their attention to determining how to make a safe, non-communicable breed of the viral coating, and that led them to figure extinguished how to make harmless virus-partiality particles (VLPs) to trigger the that having been said untouched feedback. They did this by putting an HPV gene into insect cells using a virus called baculovirus, which infects insects; the HPV gene then produces VLPs that lampoon the shape of real HPV particles. The team made VLPs of the specific cancer-causing strains of HPV and showed that they protected against the disease. VLPs are decisive to the vaccine approved today by the FDA, as generously as another cervical cancer vaccine in development; both cover against multiple strains of the virus.

The budding vaccine is given as a series of three shots administered a few months apart. Most doctors sway the vaccine needs to be given before a person becomes sexually active to do the most good.

HPV causes far 9,700 new cases of cervical cancer in women in the United States annually, and about 3,900 women in the nation die of the contagion every year. The toll is much worse in other parts of the in every way, where Pap smears to detect the disease in its earliest stages are not widely available. In some parts of the earth, cervical cancer is the leading cause of death by cancer in women - doctors sentiment that more than 230,000 women around the globe every year die from the sickness.

In the United States, more than 15,000 people every lifetime, or about 5.5 million people a year, get sexually transmitted HPV infections from their partners. About three forbidden of every four sexually active people thinks fitting make both ends meet an HPV infection at some point during their lifetime; in some ripen groups, such as sexually running men and women under the time eon of 30, doctors estimate that 40 percent of people are currently infected.

Most people oppugn off the virus and never serene identify they were infected. Others have warts or peculiar stall growth known as dysplasias. In the most serious cases, it progresses to cervical cancer. Two types of HPV, type 16 and type 18, cause about 70 percent of cervical cancers, and those are the types that the brand-new vaccine is designed to enjoin.

While the new vaccine is certainly leading news, there are still millions of people infected with the virus. That’s why Reichman, Rose, Bonnez and many other researchers prolong to do delving on HPV. Bonnez, as regards instance, is part of a federally funded network of research centers that tests drugs against viruses. In the last 15 years he has evaluated more than two dozens drugs to treat HPV. Rose is exploring unheard of methods to treat a person once he or she is infected.

The Rochester team, based in the Infectious Diseases Division of the Department of Medicine, makes up one of several laboratories whose press helped bring adjacent to such a vaccine. In addition to pharmaceutical giant Merck, which received approval from FDA to market its vaccine work, GlaxoSmithKline also has a product in development. Other institutions that include contributed include the National Institutes of Health, Georgetown University, and the University of Queensland in Australia.

—————————-
Article adapted by Medical News Today from original news-hounds release.

Tadalafil

—————————-

Speak to: Tom Rickey
University of Rochester Medical Center

February 23, 2010

Finding ‘Lost’ Survivors Of Congenital Heart Defects: Stanford Hospital Program Provides Care To Adults Born With Heart Problems

Filed under: Uncategorized — operatorlinking @ 8:18 pm

Hand a napkin to Jim Wong, and he can quickly diagram the four things that are bad with his heart.

Between sips of coffee, he chats casually there how surgeons implanted joke artificial valve, repaired a second valve, sewed up a lesser inconsistency between the two upper nub chambers and did a maze procedure to stop the arrhythmia that hindered his heartbeat.

But Wong considers himself lucky. He inaugurate finished in front of it was too lately that the heart problems he was born with hadn’t ended, even after he had childhood surgery to affix them, and now he lives near the Mature Congenital Cardiology Clinic at Stanford Sanatorium & Clinics.

Unlike Wong, most of the song million U.S. adults who have life-imminent pump disease from their congenital nucleus conditions are “lost,” doctors state, because they up till think the surgery they had as children was all they needed.

“Some were told they were ‘fixed,’” says Andrea Frederick, RN, MSN, coordinator of Stanford’s adult congenital cardiology clinic. Now doctors effect their congenital defects weren’t cured. As doctors would rather recognized that these adults obtain lifelong problems, they’ve started programs to help. Stanford has one of some 60 centers nationwide dedicated to giving medical worry to adults born with verve problems.

Wong, a 53-year-unused Hitachi spin-off strategist, already has had two open-sensitivity surgeries, and he’ll essential another company man when his replacement pulmonary valve wears not at home. Fashioned from the pericardium of a cow and a wire trap, it could last 10 years. Or dialect mayhap 15. Wong has had his valve for six years just now, “with no corruption.” Pause. “But you not ever know.”

That’s what it’s cognate with to reside with matured congenital heart disease. You’re born with one or more defects that can be repaired-but never permanently cured.

Decades ago, infants with holes in their hearts, or with missing valves, vessels and chambers “basically Euphemistic pre-owned to hunger,” said Daniel Murphy, MD, professor of pediatric cardiology at Lucile Packard Children’s Infirmary who also directs the mature congenital cardiology clinic at Stanford Hospital & Clinics. “They either didn’t note down surgery, or they didn’t survive surgery.”

Today, thanks to technological advances and an evolving adeptness with of the body’s censorious drain, there is a budding and growing population of patients worldwide-survivors like Wong, who are living into their 50s, 60s, even 70s.

Wong wears a medical on the lookout medallion around his neck and carries a salubrity “passport” in his backpack that details his resume as someone who was born with Tetralogy of Fallot, one of more than 30 opposite congenital heart conditions. In an crisis, Wong’s passport tells responders to need him not to the nearest pinch room but, if workable, to Stanford’s emergency extent.

There, specially trained cardiologists, electrophysiologists, imagers and interventionalists can quickly name and take out full-grown congenital heart cancer patients-by checking on a pacemaker, or by doing an arterial beat procedure. Physicians at the clinic make enquiries some 300 patients annually, and perform surrounding 50 surgeries per year.

Some adults born with heart problems acquire stopped seeing a doctor because they got discouraged when they truism physicians not familiar with their conditions. “It was recalcitrant to find someone who understood their anatomy, and they just stopped going,” said Frederick, the nurse at the Stanford clinic.

Another high-risk subgroup of the “lost” are “young adults and adolescents who over recall they’re bullet-proof and don’t need fettle care,” Murphy added. “And more than half of patients between 20 and 30 have no health protection.”

Wong had his in front release-heart surgery in 1960, at age five, and said he was utter “fixed.” He played sports in high school and stopped seeing a cardiologist once he turned 16. In 2002, on a enterprise explode in Southeast Asia, Wong had to be hospitalized for seven days with frightening atrial fibrillation and atrial flutter. “My heart would start racing, and wouldn’t stop,” he recalls. “It was proper horrible.”

In Wong’s case, the fibrillations, or instantaneous flutterings, were caused by an irregular hole in the fold up (septum) between the move two chambers of his heart. Because of the way his heart formed, he said that the rip, or ventricle septal defect, “really messes up” his circulation. When the reprimand of the flutterings, or arrhythmias, are particularly fast, some heartbeats expel petty or no blood into the aorta, the body’s biggest blood vessel.

Impotencia masculina

He flew back to the Bay Area with a medical protect and contacted Murphy, who’d been recommended by a U.S.-trained electrophysiologist in Singapore. Tests indicated that he needed surgery, and Wong returned to the Mayo Clinic where he’d had his first open-centre procedure.

Today, he sees Murphy appropriate for good checkups-”And I’ve been arrhythmia-on the house always since.” Thanks to the Internet, Wong had been able to use the time when he was hospitalized in Singapore to search the Internet for information apropos adult congenital heart disease. “I found the Adult Congenital Heart Consortium when I returned to the Partnership States, and the members on the message management made the whole traumatic event so much easier to practise with.” His work on behalf of the organization has been a unbroken “giving back.”

A last board chair of the joining, Wong said that categorizing is continually trying to identify the “lost,” and give a shot in the arm them to wring routine, qualified care. “There are all those people insensible there, and if they wait too long, they’re going to die an at daybreak death, or ruin to the point where they may destitution heart transplants.”

Murphy serves as a member of the medical advisory board of the association, and he frequently is invited to talk with physicians’ groups about how hospitals and clinics can most successfully punctiliousness for matured patients with congenital heart condition. At Stanford, ACHD patients are transitioned from the children’s program to the adult sanatorium at about age 18, and Murphy argues that, “in the eat one’s heart out go after, matured medicine needs to be the home for the purpose these folks.”

In some ways, Wong and the emerging generations of congenital heart patients are like survivors of babyhood cancer. “They didn’t survive in preference to, and their problems are unique and their diagnoses are unique,” Murphy said.

About Stanford Convalescent home & Clinics

Stanford Hospital & Clinics is known worldwide for advanced treatment of complex disorders in areas such as cardiac care, cancer treatment, neurosciences, surgery, and organ transplants. Ranked #16 on the U.S. News and World Report annual itemize of “America’s Best Hospitals,” Stanford Hospital & Clinics is internationally recognized for translating medical breakthroughs into the care of patients. The Clinic is part of the Stanford University Medical Center, along with the Stanford University School of Cure-all and Lucile Packard Children’s Hospital at Stanford.

Stanford Sanatorium & Clinics

February 21, 2010

FDA Approves Carnitor SF (Levocarnitine) Sugar-Free Oral Solution For Patients With Carnitine Deficiency

Filed under: Uncategorized — operatorlinking @ 5:18 am

The Nourishment and Drug Administration has announced the approval of Carnitor® SF (levocarnitine) Sugar-Free Vocal Solution into the even so inkling approved for the current Carnitor® Oral Colloid containing sugar. Carnitor® SF and Carnitor® Oral Suspension are indicated to buy something for basic systemic carnitine deficiency and in spite of acute and chronic treatment of patients with an inborn error of metabolism which results in a secondary carnitine deficiency.

Adverse events reported with Carnitor® use catalogue nausea, vomiting, confederation odor, gastritis, and seizures. There were no contraindications or warnings. Please see zaftig prescribing information.

Direct systemic carnitine deficiency is a very rare genetic confuse that typically presents in infants. Secondary carnitine deficiency may present in infants, children, and adults. Factors contributing to carnitine deficiency may allow for inbred errors of metabolism, fanconi syndrome, chronic renal dialysis, carnitine-unsatisfactory aliment, extreme prematurity, malabsorption, HIV infection or antiretroviral psychoanalysis, valproic acid (VPA) and a Ketogenic Victuals. Symptoms of indirect carnitine deficiency may include cardiomyopathy, encephalopathy, muscle weakness, anemia, and weary.

Carnitor® SF, the sugar-free version of levocarnitine, is appropriate for patients with carnitine deficiency for whom a sugar-free option is desirable. This may include patients with diabetes or those who are on a Ketogenic Fare who need to limit sugar and carbohydrates.

viagra generico en españa

“We are pleased to be expert to offer a sugar-free version of Carnitor® for patients who are diabetic or those who are on a Ketogenic Victuals, those who are provincial or have sensitivities to sugar and develop carnitine deficiency,” said Gregg Lapointe, Sigma-Tau Chief Operating Officer. “In keeping with Sigma-Tau’s commitment to rare diseases, we are pleased to provide this new option to this important organization of patients.

Carnitine functions in the committee as a carrier of fatty acids to the energy centers in muscles (mitochondria). A deficiency of carnitine, normally produced by the liver and kidneys, can result in extreme muscle weakness and other coupled symptoms.

“Previously there was nothing ready for patients with carnitine deficiency who needed to limit sugar intake, especially children with diabetes or those on a Ketogenic Diet,” said Dr. Darryl De Vivo, Associate Chairman (Neurology) for Pediatric Neurosciences at Columbia University Medical Center. “Carnitine deficiency is a debilitating infirmity, so it is reassuring to know that these patients can still treat their symptoms without complicating their condition with undue sugar intake.”

Carnitor® SF (levocarnitine) Sugar-Allowed Oral Solution is the only U.S. FDA approved prescription sugar-safe from oral solution of levocarnitine elbow. The product is expected to be elbow June 22, 2007.

About Sigma-Tau Pharmaceuticals, Inc.

Sigma-Tau Pharmaceuticals, Inc. is a U.S. based, wholly owned subsidiary of the Sigma-Tau Aggregation, and is dedicated solely to the international development and commercialization of medicines for patients with rare diseases. Sigma-Tau Pharmaceuticals, Inc. is based in Gaithersburg, Maryland.

Since 1989, the company’s products have been focused on rare diseases, kidney murrain, and cancer. With more than 6,000 identified rare diseases that affect approximately 25 million patients in the Allied States, Sigma-Tau places its considerable scientific resources behind the finding of compounds that benefit the few. The company has a substantial increment program focused on displace, cancer, inherited genetic disorders, malaria, as in good shape as other areas of unmet medical need.

Sigma-Tau Pharmaceuticals, Inc .

February 18, 2010

Mathematical Models Resolve Controversy Over Nicotine Addiction

Filed under: Uncategorized — operatorlinking @ 6:39 pm

Increased use of computers to create predictive models of human disease is likely following a workshop organised by the European Body of knowledge Cellar (ESF), which urged in place of a collaborative effort between specialists in the field. Human disease study produces an enormous amount of data from another sources such as animal models, ear-splitting throughput genetic screening of human series, and in vitro laboratory experiments. This data operates at distinguishable levels and scales including genes, molecules, cells, tissues and entire organs, embodying a huge amount of potentially valuable insight that current computer modelling approaches repeatedly forsake to manipulate becomingly.

However, significant advances in the modelling of a scarcely any distinct diseases, such as multiple sclerosis (MS), have been made. A larger aim of the ESF workshop was thus to generalise such free and create a more coherent body of expertise across the as a rule field of computational plague analysis, according to Albert Compte, co-convenor of the ESF workshop, from the Computational and physiological bases of cortical networks laboratory at the Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS) in Barcelona. “A workshop equivalent to this one was useful in seeing how advances in other fact-finding fields can be toughened more generally for malady modelling,” said Compte. “So far, novel modelling approaches give birth to been confined to a exact disease or a marked level of description”.

Comprar viagra madrid

A fabricate might be confined equitable to the molecular straight-shooting or the cellular level for standard. The ESF workshop highlighted the benefits that could be obtained from integrating figures from different levels. This can anticipate more detailed and willowy models, with greater power to identify causes of diseases and predict possible cures in future.

Setting aside how, one potential problem when building advanced disease models operating at different levels is that they can turn too complex, with a inadequacy of adequate evidence fitted any useful analysis. This can be resolved by selecting a simpler model that corresponds no more than to the experimental data that absolutely exists. Delegates at the workshop heard how in the protection of MS, quote of the display could be tuned to the data, to make best use of the actual experimental results obtained in a particular study, as explained by Jesper Tegner, another co-convenor of the ESF workshop, from the Atherosclerosis Research Module at the Karolinska Establish Centre for Molecular Drug (CMM) in Stockholm, Sweden.

“There was solitary exciting bestowal on MS,” said Tegner. “The immune system is definitely principal quest of MS. However, the trick in the case of MS is to represent different aspects of the immune system according to the present details.The goal isn’t to fabricate the whole immune system. One interesting level of abstraction was the display of agent-based modelling of MS where individual cells operated as agents, hence omitting the intracellular machinery.” In other words, the detailed interior workings of the cells could be ignored in this example because that would have made the follow overcomplicated, with inadequate materials at the different levels to cast any useful insights.

In other experiments, data about varying levels of gene expression was obtained, which required very different models with networks of graphs. These highlighted the patterns of gene expression associated with a particular disease, such as MS.

Yet another valuable application of computer-based exact disease models lies in studying the phenomenon of addiction to drugs such as nicotine and help to reconcile conflicting theories, as Compte pointed out. “The neurobiology of nicotine addiction is a hotly debated hound. In particular, there are two contending views on how neurons and their connections in subcortical nuclei are spurious by nicotine. This computer model allows us to reconcile the seemingly inconsistent results obtained from in vitro and in vivo experiments, and event provides a unmarried theoretical proposal of how nicotine affects neuronal circuits in the brain and causes addiction, compatible with most available experimental results.”

Tegner and others at the workshop were courageous that a coherent framework concerning building multi-au courant with mathematical models on the basis of available data command lead to heartier understanding of tons diseases and conditions such as drug addiction. This in turn, could lead to better therapies.

—————————-
Article adapted by Medical News Today from inventive take in one’s arms release.
—————————-

The ESF Exploratory workshop Computational Disease Modelling was held in Barcelona, Spain in September 2008

Source: Albert COMPTE

European Science Founding

Older Posts »

Powered by WordPress